Ben Tre Pharmaceutical Joint Stock Company

HOSE:DBT Stock Report

Market Cap: ₫250.5b

Ben Tre Pharmaceutical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure1.9yrs
Board average tenure9.3yrs

Recent management updates

Recent updates

CEO

Ben Tre Pharmaceutical has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Hanh Nguyen
CFO & Chairman9.8yrsno data7.46%
₫ 18.7b
Uy Nguyen
Finance Director cum Chief Accountantless than a yearno data0.30%
₫ 749.1m
Le Le
Deputy Director & Board Memberno datano datano data
Hoang Nguyen
Head of Internal Audit & Director4.1yrsno datano data

1.9yrs

Average Tenure

Experienced Management: DBT's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Hanh Nguyen
CFO & Chairman9.8yrsno data7.46%
₫ 18.7b
Le Le
Deputy Director & Board Memberno datano datano data
Hoang Nguyen
Head of Internal Audit & Director8.8yrsno datano data
Son Nguyen
Vice Chairmanno datano datano data
Van Nen Nguyen
Directorno datano datano data
Hoang Son Tran
Chief of Supervisory Boardno datano datano data
Tan Vo
Directorno datano datano data
Pham Trieu
Director10.1yrsno data19.72%
₫ 49.4b
Tung Nguyen
Director1.7yrsno datano data
Thanh Nguyen
Directorno datano data0.11%
₫ 278.2m
Duong Nguyen
HR Directorno datano data0.11%
₫ 278.2m
Nga Truong
Directorno datano data0.14%
₫ 342.4m

9.3yrs

Average Tenure

Experienced Board: DBT's board of directors are considered experienced (9.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 03:19
End of Day Share Price 2025/01/02 00:00
Earnings2020/06/30
Annual Earnings2019/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ben Tre Pharmaceutical Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution